These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A case of severe hyperammonemia and unconsciousness following sodium valproate intoxication. Lee WL; Yang CC; Deng JF; Chen YF; Lin HD; Wang PH Vet Hum Toxicol; 1998 Dec; 40(6):346-8. PubMed ID: 9830696 [TBL] [Abstract][Full Text] [Related]
25. Chromatographic procedures for the determination of felbamate in serum. Gur P; Poklis A; Saady J; Costantino A J Anal Toxicol; 1995 Oct; 19(6):499-503. PubMed ID: 8926745 [TBL] [Abstract][Full Text] [Related]
26. Determination of felbamate concentration in pediatric samples by high-performance liquid chromatography. Behnke CE; Reddy MN Ther Drug Monit; 1997 Jun; 19(3):301-6. PubMed ID: 9200771 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic interactions with felbamate. In vitro-in vivo correlation. Glue P; Banfield CR; Perhach JL; Mather GG; Racha JK; Levy RH Clin Pharmacokinet; 1997 Sep; 33(3):214-24. PubMed ID: 9314612 [TBL] [Abstract][Full Text] [Related]
28. Delayed peak serum valproic acid in massive divalproex overdose--treatment with charcoal hemoperfusion. Graudins A; Aaron CK J Toxicol Clin Toxicol; 1996; 34(3):335-41. PubMed ID: 8667473 [TBL] [Abstract][Full Text] [Related]
29. Single-dose pharmacokinetics of felbamate in patients with renal dysfunction. Glue P; Sulowicz W; Colucci R; Banfield C; Pai S; Lin C; Affrime MB Br J Clin Pharmacol; 1997 Jul; 44(1):91-3. PubMed ID: 9241102 [TBL] [Abstract][Full Text] [Related]
30. Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamate. Sachdeo R; Wagner ML; Sachdeo S; Shumaker RC; Lyness WH; Rosenberg A; Ward D; Perhach JL Epilepsia; 1999 Aug; 40(8):1122-8. PubMed ID: 10448826 [TBL] [Abstract][Full Text] [Related]
31. Felbamate in epilepsy therapy: evaluating the risks. Pellock JM Drug Saf; 1999 Sep; 21(3):225-39. PubMed ID: 10487399 [TBL] [Abstract][Full Text] [Related]
32. Thrombocytopenia in association with adjunctive felbamate use. Ney GC; Schaul N; Loughlin J; Rai K; Chandra V Neurology; 1994 May; 44(5):980-1. PubMed ID: 8190314 [No Abstract] [Full Text] [Related]
33. Low propensity of conventional antiepileptic drugs for interaction with felbamate against maximal electroshock-induced seizures in mice. Borowicz KK; Stasiuk G; Teter J; Kleinrok Z; Gasior M; Czuczwar SJ J Neural Transm (Vienna); 2000; 107(7):733-43. PubMed ID: 11005540 [TBL] [Abstract][Full Text] [Related]
34. Disposition of valproic acid in a case of fatal intoxication. Poklis A; Poklis JL; Trautman D; Treece C; Backer R; Harvey CM J Anal Toxicol; 1998 Oct; 22(6):537-40. PubMed ID: 9788531 [TBL] [Abstract][Full Text] [Related]
35. An automated analytical method for the determination of felbamate in human plasma by robotic sample preparation and reversed-phase high performance liquid chromatography. Hempenius J; Hendriks G; Hingstman J; Mensink CK; Jonkman JH; Lin CC J Pharm Biomed Anal; 1994 Nov; 12(11):1443-51. PubMed ID: 7849139 [TBL] [Abstract][Full Text] [Related]
36. Felbamate measured in serum by two methods: HPLC and capillary electrophoresis. Shihabi ZK; Oles KS Clin Chem; 1994 Oct; 40(10):1904-8. PubMed ID: 7923770 [TBL] [Abstract][Full Text] [Related]